Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

GlaxoSmithKline Fundamentals

Company Name GlaxoSmithKline Last Updated 16 Oct 2019
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 4,988.72 Market Cap (£m) 81,625.51
PE Ratio 22.20 Div per Share (p) 80.00
Div Yield 4.89 Div Cover 0.92
EPS 73.70 EPS Growth (%) 134.71
PEG 0.16 DPS Growth (%) 0.00
Debt Ratio 89.68 Debt Equity Ratio 0.59
Net Gearing 87.00 Gross Gearing 93.68
Asset Equity Ratio 15.81 Cash Equity Ratio 105.50
Quick Ratio 0.51 Current Ratio 0.75
Price To Book Value 22.23 ROCE 13.49

GlaxoSmithKline Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
H1 Dividend 08 Aug 2019 10 Oct 2019 GBX 19.00
Q1 Dividend 16 May 2019 11 Jul 2019 GBX 19.00
H2 Dividend 21 Feb 2019 11 Apr 2019 GBX 23.00 80.00
Q3 Dividend 15 Nov 2018 10 Jan 2019 GBX 19.00
H1 Dividend 09 Aug 2018 11 Oct 2018 GBX 19.00
Q1 Dividend 10 May 2018 12 Jul 2018 GBX 19.00
H2 Dividend 22 Feb 2018 12 Apr 2018 GBX 23.00 80.00
Q3 Dividend 09 Nov 2017 11 Jan 2018 GBX 19.00
H1 Dividend 10 Aug 2017 12 Oct 2017 GBX 19.00
Q1 Dividend 11 May 2017 13 Jul 2017 GBX 19.00
H2 Dividend 23 Feb 2017 13 Apr 2017 GBX 23.00 80.00
Q3 Dividend 03 Nov 2016 12 Jan 2017 GBX 19.00
H1 Dividend 11 Aug 2016 13 Oct 2016 GBX 19.00
Q1 Dividend 12 May 2016 14 Jul 2016 GBX 19.00
Special Dividend 18 Feb 2016 14 Apr 2016 GBX 20.00
H2 Dividend 18 Feb 2016 14 Apr 2016 GBX 23.00 80.00
Q3 Dividend 12 Nov 2015 14 Jan 2016 GBX 19.00
H1 Dividend 13 Aug 2015 01 Oct 2015 GBX 19.00
Q1 Dividend 14 May 2015 09 Jul 2015 GBX 19.00
H2 Dividend 19 Feb 2015 09 Apr 2015 GBX 23.00 80.00
Q3 Dividend 06 Nov 2014 08 Jan 2015 GBX 19.00

GlaxoSmithKline Company Financials

Assets (£m) 2018 2017 2016
Tangible Assets 11,058 10,860 10,808
Intangible Assets 22,991 23,296 24,741
Investments 7,090 6,318 6,821
Total Fixed Assets 41,139 40,474 42,370
Stocks 5,476 5,557 5,102
Debtors 6,423 6,000 6,026
Cash & Equivalents 3,874 3,833 4,897
Other Assets 1,154 517 686
Total Assets 58,066 56,381 59,081
Liabilities (£m) 2018 2017 2016
Creditors within 1 year 22,491 26,569 19,001
Creditors after 1 year 31,903 26,323 35,117
Other Liabilities 0 0 0
Total Liabilities 54,394 52,892 54,118
Net assets 3,672 3,489 4,963
Equity (£m) 2018 2017 2016
Called up share capital 1,345 1,343 1,342
Share Premium 3,091 3,019 2,954
Profit / Loss 4,800 3,525 1,939
Other Equity 2,061 2,047 2,220
Preference & Minorities -688 3,557 3,839
Total Capital Employed 3,672 3,489 4,963
Ratios 2018 2017 2016
Debt Ratio 89.68 88.30 87.62
Debt-to-Equity 0.59 0.50 0.65
Net Gearing 87.00 87.01 83.31
Gross Gearing 93.68 93.81 91.60
Assets / Equity 15.81 16.16 11.90
Cash / Equity 105.50 109.86 98.67
EPS 73.70 31.40 18.80
Cash Flow (£m) 2018 2017 2016
Cash from operating activities 8,421 6,918 6,497
Cashflow before financing 6,868 5,475 5,228
Increase in Cash 479 -905 -1,164
Income (£m) 2018 2017 2016
Turnover 30,821 30,186 27,889
Cost of sales 10,241 10,342 9,290
Gross Profit 20,580 19,844 18,599
Operating Profit 5,483 4,087 2,598
Pre-Tax profit 4,800 3,525 1,939
Profit / Loss for the year 1,345 1,343 1,342

GlaxoSmithKline Company Background

Sector Pharmaceuticals
Activities GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D. GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.8bn/$5bn.
Latest Interim Date 24 Jul 2019
Latest Fiscal Year End Date 06 Feb 2019

GlaxoSmithKline Directors

Appointed Director Position
01 Jan 2017 Emma Natasha Walmsley Chief Executive Officer
14 Jan 2019 Iain James Mackay Chief Financial Officer
01 Jan 2018 Dr Hal Barron Chief Scientific Officer
01 Jan 2015 Sir Philip Roy Hampton Non-Executive Chairman
01 Jul 2012 Lynn Laverty Elsenhans Non-Executive Director
01 Sep 2017 Dr Laurie Hollis Glimcher Non-Executive Director
01 Jan 2016 Dr Jesse Goodman Non-Executive Director
01 Jan 2015 Urs Rohner Non-Executive Director
01 Apr 2011 Judith Carol Lewent Non-Executive Director
01 Jul 2016 Dr Vivienne Cox Non-Executive Director
01 Sep 2015 Manvinder Singh Banga Non-Executive Director

GlaxoSmithKline Contact Details

Company Name GlaxoSmithKline
Company Address 980 Great West Road, Brentford, Middlesex TW8 9GS.
Company Telephone +44 (0)20 8047 5000
Company Website http://www.gsk.com/

GlaxoSmithKline Advisors

Auditor Name PricewaterhouseCoopers LLP
Auditor Address 1 Embankment Place, London WC2N 6RH.
Auditor Website http://www.pwc.co.uk/
Auditor Telephone +44(0) 20 7583 5000
Registrar Name Equiniti
Registrar Address Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA.
Registrar Website http://www.equiniti.com/
Registrar Telephone 0871 384 2030
Broker Name Jefferies Hoare Govett
Broker Address Vintners Place, 68 Upper Thames Street, London EC4V 3BJ.
Broker Website http://www.jefferies.com/
Broker Telephone +44 (0)20 7029 8000
Adviser Name n/a
Adviser Address n/a
Adviser Website n/a
Adviser Telephone n/a
Solicitor Name n/a
Solicitor Address n/a
Solicitor Website n/a
Solicitor Telephone n/a
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a